Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05873153 · ClinicalTrials.gov registry record · NA

A Study of Cardiovascular Disparities in the Greater Mankato Somali Community to Prevent Hypertension

A NA study of Hypertension, sponsored by Mayo Clinic.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05873153: Active NA study of Hypertension, sponsored by Mayo Clinic.

NCT05873153 is a NA study of Hypertension that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05873153, a NA study of Hypertension, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to develop ways to reduce hypertension-management-related disparities in the Greater Mankato Area Somali population.

Primary Outcome

Number of subjects to follow up with a primary care provider

Conditions Studied

Interventions

  • BEHAVIORAL Health Education
  • OTHER Home Blood Pressure Monitor

Study Locations (1)

Minnesota

  • Erin Westfall - Mankato

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-02-21
Est. Completion 2026-06-30
Phase NA
Mayo Clinic

2,844 total trials

What the registry record for NCT05873153 still lists

NCT05873153 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Health Education is the first listed.

NCT05873153 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT05873153 about?

NCT05873153 is a clinical study titled "A Study of Cardiovascular Disparities in the Greater Mankato Somali Community to Prevent Hypertension". The purpose of this research is to develop ways to reduce hypertension-management-related disparities in the Greater Mankato Area Somali population.

What is the current status of trial NCT05873153?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-02-21. Estimated completion is 2026-06-30.

What conditions does trial NCT05873153 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT05873153?

The interventions under investigation include: Health Education (BEHAVIORAL), Home Blood Pressure Monitor (OTHER).

Who is sponsoring clinical trial NCT05873153?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05873153 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05873153's enrollment target sits among peer trials

100 292nd of 470 higher than 170 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05873153, the US trial registry maintained by the National Library of Medicine. NCT05873153 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.